This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty ...

The metabolic syndrome represents a specific cluster of phenotypes that increase the risk for coronary heart disease and type-2 diabetes mellitus. 1, 2, 3, 4 Owing to ...

After 6 weeks, significantly more patients reached goal BP after one titration step of combination therapy vs. two titration steps of monotherapy (31% vs. 12.6%; p <0.001; Figure 2). The changes from ...

Torrent Pharmaceuticals Limited is once again expanding its voluntary recall of contaminated sartans to include three more lots of losartan potassium and two more lots of losartan-hydrochlorothiazide ...

Participants assigned losartan/hydrochlorothiazide had a 1-mmol/L increase in two-hour OGTT glucose values at week 12 and a 1.6-mmol/L increase for week 52 (P <.001 for both) compared with ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...

The maker of Losartan has widened a recall of the generic blood pressure medicine for the fifth time, according to the U.S. Food and Drug Administration, which warned that some pills may be tainted ...

OTTAWA, March 9, 2019 /CNW/ - Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and ...

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens. July 13, ...

The Food and Drug Administration has once again expanded its recall of widely prescribed blood pressure drugs after trace amounts of a chemical linked to cancer was detected during testing. The latest ...